INVO Fertility Corp (IVF) - Long-Term Liabilities to Capital

This daily price chart for INVO Fertility Inc (IVF) illustrates a debt-to-equity ratio of 0.13. INVO Fertility Inc (IVF) is optimizing costs by outsourcing the production of plastic components to verified third-party contractors. The business is based on the creation of automated INVOcell systems for embryo development, minimizing manual labor. Financial stability relies on steady interest in infertility therapy, which guarantees a predictable cash flow within the private healthcare sector.

Long-Term Debt to Capital: INVO Bioscience, Inc. (IVF) for 04/29/2025 - 10/30/2026

Analytical breakdowns for INVO Fertility Inc

- stock price and consensus target price:
Quote Chart INVO Bioscience|IVF - Analyst Consensus Forecast
- market capitalization indicators:
Market Value INVO Fertility Inc|IVF - Enterprise Value
- book value of equity indicators:
Accounting Value per Share INVO Fertility|IVF - Book Capitalization|Market Capitalization to Book Value invobioscience.com|IVF - Company Total Assets
- debt and solvency information:
Total Debt to Capital INVO Fertility Inc|IVF - Long-Term Debt to Equity|Short-Term Debt to Equity invobioscience.com|IVF - Company Aggregate Debts|Debts to Net Assets INVO Fertility Inc|IVF - Company Long-Term Liabilities|Current Liabilities INVO Fertility|Immediate Liquidity invobioscience.com
- company profitability and valuation multiples indicators:
IVF - Net Profit
Summary company analysis:INVO Fertility Inc

This ratio determines the dependence of long-term financing on the issuer's own resources. By analyzing the level of long-term debt load relative to equity, an investor assesses the stability of the balance sheet structure against credit risks. The ratio of liabilities exceeding one year to equity reveals the company's degree of financial leverage. For INVO Fertility Inc (IVF), this is critical when scaling INVOcell systems through partnerships with IVF clinics. Debt optimization ensures the stable development of joint affordable medicine projects.

Competing companies

Boston Scientific Corp - Long-Term Liabilities to Equity|Long-Term Debt to Capital EW|RMD - Long-Term Liabilities to Capital|Long-Term Debt to Capital PODD (Insulet Corporation)|ZBH - Long-Term Debt to Equity Ratio|CooperCompanies - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Invisalign ALGN|GMED: Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Long-Term Debt to Capital|Long-Term Debt to Equity Alphatec Holdings, Inc.|Long-Term Debt to Equity AORT|Long-Term Debt to Capital ENOV|Ratio of Long-Term Indebtedness to Capital Integra LifeSciences Corp|Motiva - Long-Term Debt to Equity Ratio|BBNX (iLet Bionic Pancreas) - Long-Term Liabilities to Equity|IRADIMED CORPORATION - Long-Term Debt to Capital|Long-Term Liabilities to Capital embecta.com|TNDM: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio AXGN|Long-Term Debt to Equity Ratio SIBN|OFIX: Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Bioventus Inc. (BVS)|Long-Term Debt to Equity Ratio orthopediatrics.com KIDS|Long-Term Debt to Capital TMCI (Treace Medical Concepts, Inc.)|Blade Air Mobility (SRTA) - Long-Term Liabilities to Capital|Carlsmed Corp - Long-Term Debt to Capital|RXST (RxSight Ophthalmic) - Long-Term Debt to Capital Ratio|CLPT: Long-Term Debt to Capital|STXS - Ratio of Long-Term Indebtedness to Capital|STIM (Neuronetics) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Sight Sciences Inc. (SGHT)|Long-Term Debt to Capital OBIO|Long-Term Debt to Capital anikatherapeutics.com (ANIK)|Long-Term Debt to Equity InspireMD, Inc. NSPR|Jin Medical International Ltd. - Long-Term Debt to Equity|VANI: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient XTNT (Xtant Medical Holdings)|NMTC: Long-Term Debt to Capital|Long-Term Liabilities to Capital Modular Medical, Inc. (MODD)|Long-Term Debt to Equity Myomo, Inc.|COCH - Long-Term Indebtedness to Equity|Long-Term Debt to Equity Ratio VVOS (Vivos Therapeutics, Inc.)|Long-Term Debt to Capital enVVeno Medical Corporation (NVNO)|Long-Term Debt to Capital SINT (Sintx Technologies, Inc.)|Ratio of Long-Term Indebtedness to Capital Tenon Medical Inc (TNON)|LFWD - Long-Term Debt to Equity|Long-Term Liabilities to Equity AMIX|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Axonics Inc.|BIOL (Biolase, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Dynatronics Corp. DYNT|Long-Term Debt to Equity Paragon 28, Inc. (FNA)|invobioscience.com - Long-Term Debt to Capital Ratio